MONTHLY BCG PRECEDED BY FIVE WEEKLY MITOMYCIN C INSTILLATIONS GIVES AN EXCELLENT TUMOR CONTROL IN THE PROPHYLAXIS OF RECURRENT PAPILLARY SUPERFICIAL BLADDER CARCINOMA (pTa to pT1) - NO USE OF ALTERNATING INTERFERON-alpha 2B MONTHLY WITH BCG

1999 ◽  
pp. 286
Author(s):  
Eero Kaasinen ◽  
Erkki Rintala ◽  
Anna-Kaisa Pere ◽  
Jukka Kallio ◽  
Veli-Matti Puolakka ◽  
...  
Keyword(s):  
Mitomycin C ◽  
Interferon Alpha ◽  
Bladder Carcinoma ◽  
Tumor Control ◽  
Interferon Alpha 2B ◽  
Superficial Bladder Carcinoma

scholarly journals Bladder perforation after immediate postoperative intravesical instillation of mitomycin C

2013 ◽  
Vol 4 (1) ◽  
pp. 1 ◽  
Author(s):  
Darwin Lim ◽  
Jonathan I. Izawa ◽  
Paul Middlebrook ◽  
Joseph L. Chin
Keyword(s):  
Intensive Care ◽  
Single Dose ◽  
Mitomycin C ◽  
Male Patient ◽  
Transurethral Resection ◽  
Bladder Carcinoma ◽  
Adjunctive Therapy ◽  
Intravesical Instillation ◽  
Recurrence Rates ◽  
Superficial Bladder Carcinoma

Intravesical chemotherapy after transurethral resection of a bladdertumour (TURBT) has been observed to significantly decreaserecurrence rates compared to TURBT alone. Though immediatepostoperative intravesical treatment with chemotherapeutic agentsafter transurethral resection for superficial bladder carcinoma isgenerally considered a safe and effective adjunctive therapy indecreasing recurrence rates, its instillation is not always completelyinnocuous. Lately, a more serious complication of bladderperforation associated with immediate instillation of intravesicalmitomycin C (MMC) after TURBT was reported. We reportour own experience of a male patient with bladder perforationafter an early instillation of a single dose of MMC. In this case,systemic toxicity occurred which required intensive care aftersurgical repair.

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma

2005 ◽  
Vol 95 (9) ◽  
pp. 1206-1210 ◽  
Author(s):  
Rob J. Skyrme ◽  
A. Jane French ◽  
Shibendra N. Datta ◽  
Richard Allman ◽  
Malcolm D. Mason ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Mitomycin C ◽  
Bladder Carcinoma ◽  
Phase 1 ◽  
Phase 1 Study ◽  
Aminolaevulinic Acid ◽  
Superficial Bladder Carcinoma

Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance

2018 ◽  
Vol 93 (11) ◽  
pp. 558-561
Author(s):  
T.A. Chaparro Tapias ◽  
A.L. Díaz Díaz ◽  
R. Secondi ◽  
H. Coy Villamil ◽  
J.C. Sánchez España
Keyword(s):  
Mitomycin C ◽  
Interferon Alpha ◽  
Conjunctival Melanoma ◽  
Interferon Alpha 2B

5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA

1999 ◽  
Vol 161 (4) ◽  
pp. 1124-1127 ◽  
Author(s):  
PER-UNO MALMSTROM ◽  
HANS WIJKSTROM ◽  
CARL LUNDHOLM ◽  
KENNETH WESTER ◽  
CHRISTER BUSCH ◽  
...  
Keyword(s):  
Prospective Study ◽  
Mitomycin C ◽  
Bladder Carcinoma ◽  
Bacillus Calmette Guerin ◽  
Superficial Bladder Carcinoma

scholarly journals Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2b

2014 ◽  
Vol 157 (2) ◽  
pp. 287-293.e2 ◽  
Author(s):  
Jenna Besley ◽  
Juanita Pappalardo ◽  
Graham A. Lee ◽  
Lawrence W. Hirst ◽  
Stephen J. Vincent
Keyword(s):  
Risk Factors ◽  
Mitomycin C ◽  
Interferon Alpha ◽  
Ocular Surface ◽  
Ocular Surface Squamous Neoplasia ◽  
Interferon Alpha 2B
Sign in / Sign up

Export Citation Format

Share Document